DOCSLIB.ORG

Product Catalogue BD Diagnostics - Diagnostic Systems

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Product Catalogue BD Diagnostics - Diagnostic Systems Product Catalogue BD Diagnostics - Diagnostic Systems BD Diagnostics Erembodegem-Dorp 86 B-9320 Erembodegem Belgium Tel. +32 53 720 550 Europe Catalogue BD Diagnostics Diagnostic Systems North West Catalogue Product Product Fax +32 53 720 549 e-mail: [email protected] or [email protected] BD Diagnostics Herstedøstervej 27-29 Bygning A, 2.tv. 2620, Albertslund Denmark Tel. +45 4343 4566 Fax +45 8851 0001 E-mail: [email protected] BD Diagnostics Käyntiosoite Becton Dickinson Oy Äyritie 18 01510 Vantaa Finland Tel. +358 (0)9 8870 780 E-mail: [email protected] BD Diagnostics Postbus 2130 NL-4800 CC Breda Netherlands Tel. +31 20 654 52 25 Fax +31 20 582 94 21 e-mail: [email protected] or [email protected] BD Diagnostics c/o Merkantilservice Jonsvannsveien 82 N-7050, Trondheim Norway Tel. +47 73 59 12 00 E-mail: [email protected] BD Diagnostics Årstaängsvägen 25 Box 472 04 100 74, Stockholm Sweden Tel. +46 (0)8 775 51 00 Fax +46 (0)8 645 08 08 E-mail: [email protected] Your local distributor BD Diagnostics The Danby Building Edmund Halley Road Oxford Science Park Oxford OX4 4DQ UK Tel. +44 (0)1865 781666 Fax +44 (0)1865 781627 - for ordering +44 (0)1865 781578 - for general enquiries Email: [email protected] Website: www.bd.com/uk BD - your partner in excellence BD is a leading global medical of diagnosing infectious diseases approximately 30,000 people in technology company that develops, and cancers, and advancing more than 50 countries throughout manufacturers and sells medical research, discovery and production the world. The Company serves devices, instrument systems of new drugs and vaccines. BD’s healthcare institutions, life science and reagents. The Company is capabilities are instrumental in researchers, clinical laboratories, dedicated to improving people’s combating many of the world’s the pharmaceutical industry and health throughout the world. BD is most pressing diseases. Founded in the general public. focused on improving drug delivery, 1897 and headquartered in Franklin enhancing the quality and speed Lakes, New Jersey, BD employs BD Medical BD Diagnostics BD Biosciences > Diabetes Care > Diagnostic Systems > Cell Analysis > Medical Surgical Systems > Preanalytical Systems > Pharmaceutical Systems BD Medical is among the world’s BD Diagnostics is a leading BD Biosciences is a world leading suppliers of medical provider of products for the leader in bringing innovative devices and a leading innovator safe collection and transport of diagnostic and research tools in injection- and infusion-based diagnostics specimens, as well as to life science researchers, drug delivery since 1906, when the instruments and reagent systems clinical researchers, laboratory Company built the first-ever facility to accurately detect a broad range professionals and clinicians who in the U.S. to manufacture needles of infectious diseases, healthcare- are involved in basic research, and syringes. The BD Medical associated infections (HAIs) and drug discovery and development, segment is focused on providing cancers. The BD Diagnostics biopharmaceutical production innovative solutions to reduce segment focuses on improving and disease management. The BD the spread of infection, enhance health outcomes for patients Biosciences segment is focused on diabetes treatment and advance by providing laboratories with continually advancing the science drug delivery. solutions that improve quality, and applications associated with enhance laboratory system cellular analysis. productivity and inform medical decisions. 1 Contents Blood Culture Systems Collection & Transport Systems BD Difco™ Inoculation Loops & Needles ................................................................................... 12 BD Specimen Collection & Transport Systems ........................................................................... 12 Data Management, Statistics & Epidemiology BD EpiCenter™ Advanced Data Management System ............................................................... 17 Dehydrated Culture Media (DCM) BD Culture Media & Ingredients ............................................................................................... 20 Prepared Media Automated Plate Streaking ...................................................................................................... 61 BD Prepared Plated Media (PPM) .............................................................................................. 61 BD BBL™ Prepared Tubed Media (PTM) ..................................................................................... 72 BD Kiestra™ Lab Automation .................................................................................................... 81 Bottled Media ......................................................................................................................... 81 BD FACS MicroCount™ BD FACS MicroCount™ System ................................................................................................. 96 BD FACS MicroCount™ Applications Reagents Order Lists......................................................... 97 Direct Testing Systems & Serology BD Chromatographic Immunoassays ...................................................................................... 100 Enzymes ................................................................................................................................ 101 BD Latex Agglutination Test Kits ............................................................................................ 101 Syphilis Testing ...................................................................................................................... 102 Coagulase Testing .................................................................................................................. 103 Buffers & Diluents .................................................................................................................. 104 Antisera ................................................................................................................................. 104 Antigens ................................................................................................................................ 109 Anaerobic Systems BD GasPak™ EZ Products ........................................................................................................ 113 BD GasPak™ 100 & 150 Systems ............................................................................................ 114 BD GasPak™ & BD Bio-Bag™ Pouch Systems ........................................................................... 115 BD Anaerobic Systems - Accessories ....................................................................................... 115 2 Identification & Susceptibility Testing BD Difco™ - BD BBL™ - Stains, Droppers & Indicators .............................................................. 119 BD Manual Identification ....................................................................................................... 123 BD Microtrol™ Quality Control Organisms .............................................................................. 125 BD Taxo™ Manual Differentiation ........................................................................................... 127 BD Phoenix™ Automated Identification & Susceptibility Testing ............................................... 129 Manual Susceptibility Testing ................................................................................................. 131 Molecular Diagnostics & Womens’ Health Thrush and Bacterial Vaginosis Testing ................................................................................... 139 Chlamydia and Gonorrhoea Testing ....................................................................................... 139 BD Viper™ .............................................................................................................................. 143 BD TriPath Cervical Cytology Cytology Sample Preparation ................................................................................................. 148 Cytology Slide Preparation ..................................................................................................... 151 Cytology Screening ................................................................................................................ 151 Cytology and Molecular Sample Preparation .......................................................................... 151 BD MAX™ System BD MAX™ System .................................................................................................................. 153 BD MAX™ IVD assays ............................................................................................................. 153 Diagenode Partner Assays for BD MAX™ ................................................................................ 154 BD MAX™ Open System Reagents .......................................................................................... 155 BD GeneOhm Rapid Nucleic Acid Based Diagnostics BD GeneOhm™ Rapid HCAI Testing ........................................................................................ 158 Mycobacteria Testing Systems BD BACTEC™ MGIT™ Automated Mycobacteria Testing .......................................................... 162 BD Manual Mycobacteria Testing ........................................................................................... 164 BD Mycobacteria Specimen Collection,
Load more

Recommended publications
  • Commercial Model of the Future
    BioPharma BD Quarterly Newsletter Q2 2018 Syneos Health Consulting Commercial Strategy & Planning | Portfolio Strategy Solution Center Syneos Health BioPharma BD Quarterly Newsletter | Q2 2018 Q2 FDA Approvals | Q3 PDUFA Dates | Q2 Deal Summary | Q2 Mergers & Acquisitions | Q2 Partnerships | Q2 Asset Purchases Q2 FDA Approvals1,2 In order of 2020 sales forecast No sales listed Aimovig (erenumab) | Novartis / Amgen (co- Akynzeo IV (fosnetupitant) | Helsinn Group commercialize) . Prevention of acute and delayed nausea Migraine, first CGRP receptor blocker associated with cancer chemotherapy . 2020E Sales: $470M Bendamustine HCl Injection (bendamustine AndexXa (andexanet alfa) | Portola hydrochloride) | Spectrum Pharmaceuticals / Pharmaceuticals Eagle Pharmaceuticals (co-promotion Neel Patel . Used for uncontrolled bleeding in patients that agreement) used rivaroxaban and apixaban . Chronic lymphocytic leukemia Managing Director . 2020E Sales: $258M [email protected] Consensi (amlodipine besylate) | Kitov / Dexcel Fulphila (pegfilgrastim) | Mylan / Biocon Pharma Technology (cooperation agreement- (partnership) Dexcel will develop drugs final formulation-Kitov . Decrease incidence of infection, as manifested by pays Dexcel $3.5M for company’s facilities) febrile neutropenia . Amlodipine for hypertension and celecoxib for . 2020E Sales: $244M osteoarthritis Lokelma (sodium zirconium cyclosilicate) | Crysvita (burosumab) | Ultragenyx AstraZeneca / Incyte (clinical trial collaboration) Pharmaceutical . Treatment of hyperkalemia in adults
    [Show full text]
  • Reverse Blot Hybridization Assay
    Detection of Waterborne Pathogens by Polymerase Chain Reaction- Reverse Blot Hybridization Assay Yeonim Choi The Graduate School Yonsei University Department of Biomedical Laboratory Science Detection of Waterborne Pathogens by Polymerase Chain Reaction- Reverse Blot Hybridization Assay A Dissertation Submitted to the Department of Biomedical Laboratory Science and the Graduate School of Yonsei University in partial fulfillment of the requirements for the degree of Doctor of Philosophy Yeonim Choi July 2011 G This certifies that the dissertation of Yeonim Choi is approved. ๤๤๤๤๤๤๤๤๤๤๤๤๤๤๤๤๤๤๤ Thesis Supervisor : Hyeyoung Lee ๤๤๤๤๤๤๤๤๤๤๤๤๤๤๤๤๤๤๤ Ok Doo Awh : Thesis Committee Member ๤๤๤๤๤๤๤๤๤๤๤๤๤๤๤๤๤๤๤ Tae Ue Kim : Thesis Committee Member ๤๤๤๤๤๤๤๤๤๤๤๤๤๤๤๤๤๤๤ Jong Bae Kim : Thesis Committee Member ๤๤๤๤๤๤๤๤๤๤๤๤๤๤๤๤๤๤๤ Yong Serk Park : Thesis Committee Member The Graduate School Yonsei University July 2011 G G Dedicated to my family and my friends, who have encouraged me. G G CONTENTS LIST OF FIGURES AND TABLES ------------------------------------------------ iv ABBREVIATIONS ------------------------------------------------------------------- ix ABSTRACT IN ENGLISH ----------------------------------------------------------- x I. INTRODUCTION ------------------------------------------------------------- 1 II. MATERIALS AND METHODS -------------------------------------------- 9 1. Development of PCR-REBA targeting waterborne pathogens -------- 9 Bacterial reference strains and cultivation ------------------------------- 9 Genomic DNA extraction
    [Show full text]
  • Culture Media Edition for Industrial Microbiology LABORATORIOS CONDA S.A
    2nd Edition for Industrial Microbiology Culture Media LABORATORIOS CONDA S.A. Edited by: Laboratorios Conda S.A. © 2013. Conda S.A. All rights reserved. Printed in Spain C/ La Forja, 9 28850 - Torrejón de Ardoz, Madrid - SPAIN Tel. +34 91 761 02 00 Fax +34 91 656 82 28 C/ Berlín, 63 08029 Barcelona - SPAIN Tel. +34 93 363 72 64 / 65 Fax. +34 93 363 72 61 [email protected] [email protected] www.condalab.com Index 6 Meat & Fish Industry 20 Beer Industry 10 Water & Beverages 21 Waste Water 11 Dairy Products 23 Cosmetic Industry 15 Bakery 24 Pharmaceutical Industry 17 Processed Foods 25 Microbiology Dehydrated Culture Media Guide 19 Wines iv Media for Industrial Microbiology CULTURE MEDIA FOR INDUSTRIAL MICROBIOLOGY | 2ND EDITION Media for Industrial Microbiology 5 Culture Media for Industrial Microbiology Laboratorios CONDA, one of the world USP and AOAC standards. Strict quality leaders in the design and manufacturing of control procedures are adopted prior to, high quality culture media, currently offers during and after the manufacturing process more than 400 different products, among to ensure quality products and batch-to-batch which you will find chromogenic media, ISO- consistency. We also exert tight control over formulated media and custom-made media selection and treatment of all raw materials for many different industrial applications. and components (peptones, carbohydrates, minerals, chemicals, agar and other additives) From hygiene control, through food used in the manufacturing process. Physical- and beverage poisoning prevention, to chemical characteristics are tested, and microbiologial examination of cosmetic and media also undergo additional microbiological pharmaceutical products, CONDA supplies a tests that guarantee growth, differentiation, wide variety of different media for each field biochemical performance, recovery of small so that customers can find the most suitable inocula, selectivity, etc.
    [Show full text]
  • Product Brand List November, 2015
    Product Brand List November, 2015 BD™ BD Autoguard-N Pro™ BD CARV II™ BD 6CESS™ BD Autoguard™ BD Cato™ 6mm™ (circle design) BD AutoMagic™ BD CatoPAN™ BD A-Cath™ BD AutoNutrient™ BD Chemocato™ BD Accu-Glass™ BD AutoPap™ BD CDT™ BD Accuri™ BD AutoSceptor™ BD Cefinase™ BD Accuspray™ BD AutoShield™ BD CellFIT™ (EU only) BD Acidicase™ BD AutoShield Duo™ BD CellFIX™ (EU only) BD Activ 8™ BD Ayre Cervi-Scraper™ BD Cellmatics™ BD Activation Assist™ BD BACTEC™ BD CellQuest™ Pro BD ACTOne™ BD BACTEC FX™ BD CellWASH™ (EU only) BD Adams™ BD BACTEC™ MGIT™ BD CFlow™ BD Adsyte™ BACTEC Plus Prime™ (Japan) BD Champion™ BD Affirm™ BD Bacto™ BD Chek™ BD AICE™ BD Bact-Plate™ BD CHG™ BD A-Line™ BD Bactrol™ BD CLIC™ BD Amplatz™ BD Bactrol™ Plus BD CLyse™ BD Angiocath Plus/Pro™ (Asia only) BD BaculoGold™ BD CS Quadcount™ BD Angiocath-N™ Autoguard™ BD Barricor™ BD CSampler™ BD Angiocath™ BD BBLCrystal™ BD CX Sampler™ BD Angiocath™ Autoguard™ BD BBL™ CHROMagar (under license) BD Angio-set™ BD BBL™ Crystal™ BD Clay Adams™ BD Apem™ BD BeAware™ BD Cliniject™ BD Asepta-Cell™ BD Bio-Bag™ BD CloneCyt™ BD Asepto™ BD Biosate™ BD CloneCyt™ Plus BD Assurity Linc™ BD BiTek™ BD CMVscan™ BD Attofluor™ BD Bonnano™ BD ColorPAC™ BD Atto™ BD Busher™ BD Connecta™ BD Attovision™ BD Calibrite™ BD Cornwall™ BD Attractors™ BD Calibrite™ 3 BD CPT™ BD Autocrit™ BD CampyPak™ BD CrystalSpec™ BD Autocyte™ BD CampyPak™ Plus BD Crystal™ BD Autocyte Quic™ BD CampyPouch™ BD Autoguard Pro™ BD Campyslide™ Product Brand List November, 2015 cont'd BD CSI™ BD Easy™ BD FACSLyric™ BD CTA Medium™
    [Show full text]
  • Pocket Guide to Clinical Microbiology
    4TH EDITION Pocket Guide to Clinical Microbiology Christopher D. Doern 4TH EDITION POCKET GUIDE TO Clinical Microbiology 4TH EDITION POCKET GUIDE TO Clinical Microbiology Christopher D. Doern, PhD, D(ABMM) Assistant Professor, Pathology Director of Clinical Microbiology Virginia Commonwealth University Health System Medical College of Virginia Campus Washington, DC Copyright © 2018 Amer i can Society for Microbiology. All rights re served. No part of this publi ca tion may be re pro duced or trans mit ted in whole or in part or re used in any form or by any means, elec tronic or me chan i cal, in clud ing pho to copy ing and re cord ing, or by any in for ma tion stor age and re trieval sys tem, with out per mis sion in writ ing from the pub lish er. Disclaimer: To the best of the pub lish er’s knowl edge, this pub li ca tion pro­ vi des in for ma tion con cern ing the sub ject mat ter cov ered that is ac cu rate as of the date of pub li ca tion. The pub lisher is not pro vid ing le gal, med i cal, or other pro fes sional ser vices. Any ref er ence herein to any spe cific com mer cial prod ucts, pro ce dures, or ser vices by trade name, trade mark, man u fac turer, or oth er wise does not con sti tute or im ply en dorse ment, rec om men da tion, or fa vored sta tus by the Ameri can Society for Microbiology (ASM).
    [Show full text]
  • Laboratory Supplies and Equipment
    Laboratory Supplies and Equipment Beakers: 9 - 12 • Beakers with Handles • Printed Square Ratio Beakers • Griffin Style Molded Beakers • Tapered PP, PMP & PTFE Beakers • Heatable PTFE Beakers Bottles: 17 - 32 • Plastic Laboratory Bottles • Rectangular & Square Bottles Heatable PTFE Beakers Page 12 • Tamper Evident Plastic Bottles • Concertina Collapsible Bottle • Plastic Dispensing Bottles NEW Straight-Side Containers • Plastic Wash Bottles PETE with White PP Closures • PTFE Bottle Pourers Page 39 Containers: 38 - 42 • Screw Cap Plastic Jars & Containers • Snap Cap Plastic Jars & Containers • Hinged Lid Plastic Containers • Dispensing Plastic Containers • Graduated Plastic Containers • Disposable Plastic Containers Cylinders: 45 - 48 • Clear Plastic Cylinder, PMP • Translucent Plastic Cylinder, PP • Short Form Plastic Cylinder, PP • Four Liter Plastic Cylinder, PP NEW Polycarbonate Graduated Bottles with PP Closures Page 21 • Certified Plastic Cylinder, PMP • Hydrometer Jar, PP • Conical Shape Plastic Cylinder, PP Disposal Boxes: 54 - 55 • Bio-bin Waste Disposal Containers • Glass Disposal Boxes • Burn-upTM Bins • Plastic Recycling Boxes • Non-Hazardous Disposal Boxes Printed Cylinders Page 47 Drying Racks: 55 - 56 • Kartell Plastic Drying Rack, High Impact PS • Dynalon Mega-Peg Plastic Drying Rack • Azlon Epoxy Coated Drying Rack • Plastic Draining Baskets • Custom Size Drying Racks Available Burn-upTM Bins Page 54 Dynalon® Labware Table of Contents and Introduction ® Dynalon Labware, a leading wholesaler of plastic lab supplies throughout
    [Show full text]
  • PDF, Effect of Differences in Salt Concentration on the Quality Of
    IOP Conference Series: Earth and Environmental Science PAPER • OPEN ACCESS Effect of Differences in Salt Concentration on the Quality of Rebon Shrimp Paste (Acetes Sp) in Tegal District To cite this article: S Mulyani et al 2021 IOP Conf. Ser.: Earth Environ. Sci. 755 012051 View the article online for updates and enhancements. This content was downloaded from IP address 170.106.33.19 on 26/09/2021 at 20:52 ACHOST 2020 IOP Publishing IOP Conf. Series: Earth and Environmental Science 755 (2021) 012051 doi:10.1088/1755-1315/755/1/012051 Effect of Differences in Salt Concentration on the Quality of Rebon Shrimp Paste (Acetes Sp) in Tegal District S Mulyani 1*, P M Vestiyati 1, Kusnandar 1, H K Alamsyah 1, and S W Simanjuntak 1 1Faculty of Fisheries and Marine Science, Pancasakti University of Tegal, Indonesia *[email protected] Abstract. Rebon Shrimp Paste (RSP) in Indonesia uses different percentages of salt addition, ranging from 2 to 20% or not at all. This study aims to determine the influence of different salt concentration (5%, 10%, 15% and without salt) on the quality of RSP organoleptic, microbiological and chemical. This research was conducted in Munjung Agung, Tegal and Cirebon Fisheries Product Quality Testing and Application Laboratory. The results showed that the addition of different salt concentration (5%, 10%,15% and without salt) affected the quality of organoleptics, microbiology, and chemistry. Organoleptic quality with salt concentration of 5% and 10% favored panelists with an average value of 6.8 (not yet meeting Indonesian National Standards). The highest water content value is found in RSP that are not added salt (40,19%-43,22%) and lowest at 15% salt concentration (31,12%-34,82%) in accordance with the SNI.
    [Show full text]
  • Becton Dickinson 2000 Annual Report
    Becton, Dickinson and Company 2000 Annual Report Tools for human health 2000 Annual Report Becton, Dickinson and Company 1 Becton Drive Franklin Lakes, NJ 07417-1880 http://www.bd.com Becton, Dickinson and Company Corporate Information Board of Directors Contents Harry N. Beaty, M.D.1,4 Albert J. Costello1,6 Frank A. Olson2,5,6 James E. Perrella2,3,5 1 Letter to Shareholders Emeritus Dean–Northwestern Retired Chairman of the Board, Chairman of the Board Retired Chairman of the Board– 5 Tools for Human Health University Medical School, and President and Chief Executive and Retired Chief Executive Ingersoll-Rand Company 16 At a Glance Chairman of the Board and Officer–W.R. Grace & Co. Officer– The Hertz Corporation Alfred Sommer1,3 President–Northwestern Gerald M. Edelman, James F. Orr1,4 Dean of the Johns Hopkins 18 Nine-Year Summary University Medical Faculty M.D., Ph.D.4,5,6 Chairman, President and School of Hygiene and Public 20 Financial Review Foundation Director–The Neurosciences Chief Executive Officer– Health, and Professor of 28 Financial Statements Henry P. Becton, Jr.2,3,4 Institute, Member–The Scripps Convergys Corporation Ophthalmology, Epidemiology 49 Corporate Information: President and General Manager– Research Institute Willard J. Overlock, Jr.2,5,6 and International Health 5 1,4 Board of Directors, WGBH Educational Foundation Edward J. Ludwig Retired Partner–Goldman, Margaretha af Ugglas Clateo Castellini3,5 President and Chief Sachs & Co. Member of the Board– Corporate Officers and From laboratory Chairman of the Board–BD Executive Officer–BD Stockholm University and General Information Jarl Hjalmarson Foundation Committees Appointed by the 1 – Audit Committee to living room, Board of Directors 2 – Compensation and Benefits Committee Corporate Officers Edward J.
    [Show full text]
  • Section 13. Laboratory Considerations
    Section 13. Laboratory Considerations Table of Contents 13.1 Overview and General Guidance 13.2 Specimen Labeling 13.3 Procedures for Specimens That Cannot be Evaluated 13.4 Use of LDMS 13.5 Documentation 13.6 Urine Testing 13.6.1 Specimen Collection 13.6.2 Pregnancy Testing 13.6.3 Chlamydia and Gonorrhea Testing 13.6.4 Urine Culture 13.7 Blood Testing 13.7.1 Specimen Collection and Initial Processing 13.7.2 HIV Testing 13.7.3 Syphilis Testing 13.7.4 Hematology Testing 13.7.5 Serum Chemistries 13.7.6 Plasma Storage 13.7.7 CD4+ T Cell Count 13.7.8 HIV RNA PCR 13.7.9 HIV DNA PCR 13.8 Testing of Vaginal and Cervical Specimens 13.8.1 Vaginal pH 13.8.2 Wet Mount for Candidiasis and BV 13.8.3 Rapid Test for Trichomoniasis 13.8.4 Vaginal Gram Stain 13.8.5 Papanicolaou (Pap) Test 13.8.6 Self-Administered Vaginal Swabs for PK and biomarker testing 13.8.7 Endocervical Swabs for Biomarker Analysis 13.8.8 Intra-Vaginal Ring Storage 13.8.9 Herpes Lesion Testing Table 13-1 Volume Guide for Plasma Storage Appendix 13-1 Overview of Laboratory Testing Locations, Specimens, and Methods for MTN-020 Appendix 13-2 MTN-020 Lab Specimen Processing Guidelines Appendix 13-3 LDMS Specimen Management Guide to Logging in MTN-020 Specimens Appendix 13-4 MTN-020 HIV Testing Algorithms Appendix 13-5 MTN Network Lab HIV Query Form Appendix 13-6 LDMS Tracking Sheets This section contains information on the laboratory procedures performed in MTN-020.
    [Show full text]
  • Antimicrobial Resistance EMERGING INFECTIOUS DISEASES Pages 681-814 Peer-Reviewed Journal Tracking and Analyzing Disease Trends Pages 681–814
    Vol 13, No 5, May 2007 Vol ® May 2007 Antimicrobial Resistance EMERGING INFECTIOUS DISEASES Pages 681-814 Pages Peer-Reviewed Journal Tracking and Analyzing Disease Trends pages 681–814 EDITOR-IN-CHIEF D. Peter Drotman EDITORIAL STAFF EDITORIAL BOARD Managing Senior Editor Dennis Alexander, Addlestone Surrey, United Kingdom Polyxeni Potter, Atlanta, Georgia, USA Barry J. Beaty, Ft. Collins, Colorado, USA Associate Editors Martin J. Blaser, New York, New York, USA Paul Arguin, Atlanta, Georgia, USA David Brandling-Bennet, Washington, D.C., USA Charles Ben Beard, Ft. Collins, Colorado, USA Donald S. Burke, Baltimore, Maryland, USA David Bell, Atlanta, Georgia, USA Arturo Casadevall, New York, New York, USA Jay C. Butler, Anchorage, Alaska, USA Kenneth C. Castro, Atlanta, Georgia, USA Charles H. Calisher, Ft. Collins, Colorado, USA Thomas Cleary, Houston, Texas, USA Stephanie James, Bethesda, Maryland, USA Anne DeGroot, Providence, Rhode Island, USA Brian W.J. Mahy, Atlanta, Georgia, USA Vincent Deubel, Shanghai, China Paul V. Effler, Honolulu, Hawaii, USA Nina Marano, Atlanta, Georgia, USA Ed Eitzen, Washington, D.C., USA Martin I. Meltzer, Atlanta, Georgia, USA Duane J. Gubler, Honolulu, Hawaii, USA David Morens, Bethesda, Maryland, USA Richard L. Guerrant, Charlottesville, Virginia, USA J. Glenn Morris, Baltimore, Maryland, USA Scott Halstead, Arlington, Virginia, USA Marguerite Pappaioanou, St. Paul, Minnesota, USA David L. Heymann, Geneva, Switzerland Tanja Popovic, Atlanta, Georgia, USA Daniel B. Jernigan, Atlanta, Georgia, USA Patricia M. Quinlisk, Des Moines, Iowa, USA Charles King, Cleveland, Ohio, USA Jocelyn A. Rankin, Atlanta, Georgia, USA Keith Klugman, Atlanta, Georgia, USA Didier Raoult, Marseilles, France Takeshi Kurata, Tokyo, Japan Pierre Rollin, Atlanta, Georgia, USA S.K.
    [Show full text]
  • Use of the Diagnostic Bacteriology Laboratory: a Practical Review for the Clinician
    148 Postgrad Med J 2001;77:148–156 REVIEWS Postgrad Med J: first published as 10.1136/pmj.77.905.148 on 1 March 2001. Downloaded from Use of the diagnostic bacteriology laboratory: a practical review for the clinician W J Steinbach, A K Shetty Lucile Salter Packard Children’s Hospital at EVective utilisation and understanding of the Stanford, Stanford Box 1: Gram stain technique University School of clinical bacteriology laboratory can greatly aid Medicine, 725 Welch in the diagnosis of infectious diseases. Al- (1) Air dry specimen and fix with Road, Palo Alto, though described more than a century ago, the methanol or heat. California, USA 94304, Gram stain remains the most frequently used (2) Add crystal violet stain. USA rapid diagnostic test, and in conjunction with W J Steinbach various biochemical tests is the cornerstone of (3) Rinse with water to wash unbound A K Shetty the clinical laboratory. First described by Dan- dye, add mordant (for example, iodine: 12 potassium iodide). Correspondence to: ish pathologist Christian Gram in 1884 and Dr Steinbach later slightly modified, the Gram stain easily (4) After waiting 30–60 seconds, rinse with [email protected] divides bacteria into two groups, Gram positive water. Submitted 27 March 2000 and Gram negative, on the basis of their cell (5) Add decolorising solvent (ethanol or Accepted 5 June 2000 wall and cell membrane permeability to acetone) to remove unbound dye. Growth on artificial medium Obligate intracellular (6) Counterstain with safranin. Chlamydia Legionella Gram positive bacteria stain blue Coxiella Ehrlichia Rickettsia (retained crystal violet).
    [Show full text]
  • Syphilis Diagnosis: Three Cases with Increasing Treponemal Test Result After Therapy
    Acta Derm Venereol 2014; 94: 323–324 SHORT COMMUNICATION Syphilis Diagnosis: Three Cases with Increasing Treponemal Test Result after Therapy Henrik O. Larsson1*, Annika Johnsson2 and Anders Bredberg1 Departments of 1Medical Microbiology, and 2Dermatology and Venereology, Skane University Hospital, Lund University, Jan Waldenströms gata 59, SE- 205 02 Malmö, Sweden. *E-mail: [email protected] Accepted May 4, 2013 Epub ahead of print Oct 3, 2013 Serology is a main tool for syphilis diagnostic work used (the Captia Syphilis-Enzywell Treponema IgG and IgM, (1–3). According to a recent survey performed by the respectively, EIA from Diesse, Monteriggioni, Italy); the IgG method uses antigen-coated wells and IgM is determined by U.S. Centers for Disease Control and Prevention (CDC) capture technique; a value over 1.0 is considered to be reactive 56% of infectious disease specialists responded that they (7). Particle agglutination was done at serum dilution 80 with send a rapid plasma reagin (RPR) test to the laboratory no quantitation of the result (TPPA, Fujirebio, Tokyo, Japan). and treat presumptively for syphilis (if result is negative 18% repeat the RPR testing before treating the patient, and 17% treat only if RPR is positive) (4). However, a RESULTS clearly positive reaction may be missing at the first visit Case 1 was tested twice, at 6 days before and 112 of patients with active syphilis (5). Non-treponemal test days after treatment start (Fig. 1, upper panel). The (e.g. RPR and Venereal Disease Research Laboratory treponemal screening value is rising from 4 to a highly (VDRL)) reactivity is known to decrease in response to reactive value of 14, while the non-treponemal VDRL therapy, in contrast to the typically life-long persistence titre decreases from a weak 1 to negativity.
    [Show full text]